 | Up a level |
2022
Lehmann, J., Thelen, M., Schran, S., Preugszat, E., Wennhold, K., Garcia-Marquez, M., Lohneis, P., Loeser, H., Popp, F., Kruger, S., Boeck, S., Ormanns, S., Rudelius, M., von Bergwelt, M., Bruns, C., Quaas, A. and Schloesser, H. (2022). ORGANIZATION, FUNCTION AND GENE EXPRESSION OF TERTIARY LYMPHOID STRUCTURES IN PANCREATIC CANCER RESEMBLES LYMPHOID FOLLICLES IN SECONDARY LYMPHOID ORGANS AND THEIR ABUNDANCE IS RELATED TO SUPERIOR SURVIVAL. J. Immunother. Cancer, 10. S. A13 - 1. LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426
2021
Hoyer, K., Hablesreiter, R., Inoue, Y., Yoshida, K., Briest, F., Christen, F., Kakiuchi, N., Yoshizato, T., Shiozawa, Y., Shiraishi, Y., Striefler, J. K., Bischoff, S., Lohneis, P., Putter, H., Blau, O., Keilholz, U., Bullinger, L., Pelzer, U., Hummel, M., Riess, H., Ogawa, S., Sinn, M. and Damm, F. (2021). A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial. EBioMedicine, 66. AMSTERDAM: ELSEVIER. ISSN 2352-3964
2018
Juhling, A., Sinn, M., Klein, F., Bischoff, S., Striefler, J. K., Pelzer, U., Oettle, H., Riess, H., Denkert, C., Blaker, H. and Lohneis, P. (2018). Tumor buds determine prognosis in resected pancreatic ductal adenocarcinoma. Oncol. Res. Treat., 41. S. 191 - 192. BASEL: KARGER. ISSN 2296-5262
2016
Knittel, G., Liedgens, P., Korovkina, D., Seeger, J. M., Al-Baldawi, Y., Vlantis, K., Fritz, C., Schaefer, S. C., Klatt, A., Scheel, A., Al-Maarri, M., Bezhanova, S., Montesinos-Rongen, M., Wolz, O. O., Reimann, M., Lohneis, P., Weber, A. N., Wunderlich, F. T., Pasparakis, M. 
ORCID: 0000-0002-9870-0966, Buettner, R., Persigehl, T., Schmitt, C. A., Odenthal, M., Frenzel, L. P., Kashkar, H. and Reinhardt, H. C.
(2016).
B CELL-SPECIFIC CONDITIONAL EXPRESSION OF MYD88P.L252P LEADS TO THE DEVELOPMENT OF DIFFUSE LARGE B CELL LYMPHOMA IN MICE.
Haematologica, 101.
S. 179 - 181.
PAVIA:
FERRATA STORTI FOUNDATION.
ISSN 0390-6078